Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896626401> ?p ?o ?g. }
- W2896626401 endingPage "6722" @default.
- W2896626401 startingPage "6705" @default.
- W2896626401 abstract "Our study aimed to explore the effects of PPIs on reversing multidrug resistance (MDR) to chemotherapy in gastric cancer by inhibiting the expression of V-ATPases and the PI3K/Akt/mTOR/HIF-1α signal pathway.The gastric cancer cell lines SGC7901 and the multidrug resistance cell lines SGC7901/MDR were pretreated by the pantoprazole or the esomeprazole, respectively. Real-time PCR was used to determine mRNA levels, and western blotting and immunofluorescent staining analyses were employed to determine the protein expressions and intracellular distributions of the V-ATPases, PI3K, Akt, mTOR, HIF-1α, P-gp and MRP1 before and after PPIs pretreatment. SGC7901/MDR cells were planted on the athymic nude mice. Then the effects of PPZ pretreatment and/or ADR were compared by determining the tumor size, tumor weight and nude mice weight.PPIs pretreatment could inhibit mRNA levels of V-ATPases, MDR1 and MRP1, PI3K, Akt, mTOR and HIF-1α. PPIs inhibited V-ATPases and down-regulated the expressions of P-gp and MRP1. And further to block the expression of mTOR by Rapamycin could obviously inhibit the expressions of HIF-1α, P-gp and MRP1 in a dose-dependent manner. Therefore, PPIs inhibited the expressions of V-ATPases and then reversed MDR of the chemotherapy in gastric cancer by inhibiting P-gp and MRP1, and it could be speculated that the mechanism might be closely related to down-regulating the PI3K/Akt/mTOR/HIF-1α signaling pathway. Meanwhile, PPIs also could inhibit the expressions of TSC1/TSC2 complex and Rheb which might be involved into regulating the signaling pathway intermediately. The weight growth rate of the mice bearing tumor in the treatment group was lower than that of the nude mice in the normal group, while the weight growth rate of the mice in control group was significantly lower than that of the normal group and the treatment group, presenting a downward trend.Therefore, PPIs inhibited the expressions of V-ATPases and then reversed MDR of the chemotherapy in gastric cancer by inhibiting P-gp and MRP1, and it could be speculated that the mechanism might be closely related to down-regulating the PI3K/Akt/mTOR/HIF-1α signaling pathway, and also to inhibiting the expressions of TSC1/TSC2 complex and Rheb which might be involved into regulating the signaling pathway intermediately." @default.
- W2896626401 created "2018-10-26" @default.
- W2896626401 creator A5003799076 @default.
- W2896626401 creator A5012718640 @default.
- W2896626401 creator A5017807720 @default.
- W2896626401 creator A5027664400 @default.
- W2896626401 creator A5050595725 @default.
- W2896626401 creator A5050626898 @default.
- W2896626401 creator A5073216396 @default.
- W2896626401 creator A5076605149 @default.
- W2896626401 creator A5079686991 @default.
- W2896626401 date "2018-10-01" @default.
- W2896626401 modified "2023-09-29" @default.
- W2896626401 title "Effects of proton pump inhibitors on reversing <br />multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1α signaling pathway <br />through TSC1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo" @default.
- W2896626401 cites W1963681917 @default.
- W2896626401 cites W1976880272 @default.
- W2896626401 cites W1977534471 @default.
- W2896626401 cites W1992500766 @default.
- W2896626401 cites W1993431258 @default.
- W2896626401 cites W2011282245 @default.
- W2896626401 cites W2017569895 @default.
- W2896626401 cites W2026106791 @default.
- W2896626401 cites W2029272680 @default.
- W2896626401 cites W2049264404 @default.
- W2896626401 cites W2065322400 @default.
- W2896626401 cites W2068734842 @default.
- W2896626401 cites W2080812054 @default.
- W2896626401 cites W2082662845 @default.
- W2896626401 cites W2088112305 @default.
- W2896626401 cites W2094941511 @default.
- W2896626401 cites W2102577783 @default.
- W2896626401 cites W2104824311 @default.
- W2896626401 cites W2105606676 @default.
- W2896626401 cites W2114189030 @default.
- W2896626401 cites W2115072149 @default.
- W2896626401 cites W2119892270 @default.
- W2896626401 cites W2120129511 @default.
- W2896626401 cites W2127207520 @default.
- W2896626401 cites W21356552 @default.
- W2896626401 cites W2136284012 @default.
- W2896626401 cites W2137579115 @default.
- W2896626401 cites W2148419067 @default.
- W2896626401 cites W2149043436 @default.
- W2896626401 cites W2154608501 @default.
- W2896626401 cites W2157393167 @default.
- W2896626401 cites W2159185818 @default.
- W2896626401 cites W2159664830 @default.
- W2896626401 cites W2234115940 @default.
- W2896626401 cites W2280443309 @default.
- W2896626401 cites W2332099868 @default.
- W2896626401 cites W2335253691 @default.
- W2896626401 cites W2402432029 @default.
- W2896626401 cites W2472377024 @default.
- W2896626401 cites W2479507898 @default.
- W2896626401 cites W2522804738 @default.
- W2896626401 cites W2531977297 @default.
- W2896626401 cites W2533005202 @default.
- W2896626401 cites W2891238555 @default.
- W2896626401 cites W628038580 @default.
- W2896626401 doi "https://doi.org/10.2147/ott.s161198" @default.
- W2896626401 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6188003" @default.
- W2896626401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30349304" @default.
- W2896626401 hasPublicationYear "2018" @default.
- W2896626401 type Work @default.
- W2896626401 sameAs 2896626401 @default.
- W2896626401 citedByCount "37" @default.
- W2896626401 countsByYear W28966264012019 @default.
- W2896626401 countsByYear W28966264012020 @default.
- W2896626401 countsByYear W28966264012021 @default.
- W2896626401 countsByYear W28966264012022 @default.
- W2896626401 countsByYear W28966264012023 @default.
- W2896626401 crossrefType "journal-article" @default.
- W2896626401 hasAuthorship W2896626401A5003799076 @default.
- W2896626401 hasAuthorship W2896626401A5012718640 @default.
- W2896626401 hasAuthorship W2896626401A5017807720 @default.
- W2896626401 hasAuthorship W2896626401A5027664400 @default.
- W2896626401 hasAuthorship W2896626401A5050595725 @default.
- W2896626401 hasAuthorship W2896626401A5050626898 @default.
- W2896626401 hasAuthorship W2896626401A5073216396 @default.
- W2896626401 hasAuthorship W2896626401A5076605149 @default.
- W2896626401 hasAuthorship W2896626401A5079686991 @default.
- W2896626401 hasBestOaLocation W28966264011 @default.
- W2896626401 hasConcept C126322002 @default.
- W2896626401 hasConcept C133936738 @default.
- W2896626401 hasConcept C185592680 @default.
- W2896626401 hasConcept C2776694085 @default.
- W2896626401 hasConcept C2778239845 @default.
- W2896626401 hasConcept C501593827 @default.
- W2896626401 hasConcept C502942594 @default.
- W2896626401 hasConcept C55493867 @default.
- W2896626401 hasConcept C62478195 @default.
- W2896626401 hasConcept C71924100 @default.
- W2896626401 hasConcept C75217442 @default.
- W2896626401 hasConcept C86554907 @default.
- W2896626401 hasConcept C86803240 @default.
- W2896626401 hasConcept C98274493 @default.
- W2896626401 hasConceptScore W2896626401C126322002 @default.
- W2896626401 hasConceptScore W2896626401C133936738 @default.